Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people

  • Technology appraisal guidance
  • TA455
  • Published: 
Download guidance (PDF)

3 Evidence

The appraisal committee (section 7) considered evidence from a number of sources. See the committee papers for full details of the evidence.